Table 1.
Clinical characteristics of 123 NPC patients
| Characteristic | Number of patients |
|---|---|
| Sex | |
| Male | 95 (77.2%) |
| Female | 28 (22.8%) |
| Age (years) | |
| Median | 46 |
| ≤46 | 66 |
| >46 | 57 |
| Overall survival (months) | |
| Median | 57 |
| Range | 6–120 |
| Progression-free survival (months) | |
| Median | 52 |
| Range | 5–118 |
| Clinical stage | |
| I+II | 32 (26.0%) |
| III+IV | 91 (74.0%) |
| Relapse/metastasis | |
| No | 86 (69.9%) |
| Yes | 37 (30.1%) |
| Therapeutic modality | |
| No treatment | 17 (13.8%) |
| Radiotherapy alone | 83 (67.5%) |
| Chemotherapy alone | 1 (0.8%) |
| Radiochemotherapy | 22 (17.9%) |
| WHO histological classification | |
| NKUC | 101 (82.1%) |
| NKDC | 22 (17.9%) |
| KSCC | 0 (0%) |
Abbreviations: NPC, nasopharyngeal carcinoma; WHO, World Health Organization; NKUC, non-keratinizing undifferentiated carcinoma; NKDC, non-keratinizing differentiated carcinoma; KSCC, keratinizing squamous cell carcinoma.